Genexpath

Develops, produces, and markets innovative diagnostic tests based on next-generation sequencing to better characterize non-Hodgkin lymphomas and sarcomas. These patented tests offer rapid and reliable diagnoses without requiring additional equipment, facilitating their adoption in routine clinical practice and optimizing patient care.